{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:35:53Z","timestamp":1793684153780,"version":"4.5.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012834","name":"Gifu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jsbmb.2025.106874","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:35:04Z","timestamp":1759797304000},"page":"106874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Canine aldo-keto reductase 1C3 (AKR1C3\/PGFS) exhibits 17\u03b2\/20\u03b1-hydroxysteroid dehydrogenase activity and is inhibited by trilostane"],"prefix":"10.1016","volume":"255","author":[{"given":"Satoshi","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riri","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Suenami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2025.106874_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111111","article-title":"Aldo-keto reductase (AKR) superfamily website and database: an update","volume":"398","author":"Andress Huacachino","year":"2024","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2025.106874_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jsbmb.2025.106874_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/03602532.2013.853078","article-title":"Carbonyl reduction pathways in drug metabolism","volume":"46","author":"Mal\u00e1tkov\u00e1","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jsbmb.2025.106874_bib5","article-title":"AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jsbmb.2025.106874_bib6","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1016\/S0021-9258(18)88884-6","article-title":"Enzymatic formation of prostaglandin F2\u03b1 from prostaglandin H2 and D2. purification and properties of prostaglandin f synthetase from bovine lung","volume":"260","author":"Watanabe","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2025.106874_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0003-9861(92)90539-9","article-title":"Purification and characterization of prostaglandin f synthase from bovine liver","volume":"296","author":"Chen","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2025.106874_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.anireprosci.2007.06.026","article-title":"Canine prostaglandin F2\u03b1 receptor (FP) and prostaglandin F2\u03b1 synthase (PGFS): molecular cloning and expression in the corpus luteum","volume":"107","author":"Kowalewski","year":"2008","journal-title":"Anim. Reprod. Sci."},{"key":"10.1016\/j.jsbmb.2025.106874_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1095\/biolreprod.113.109918","article-title":"Biosynthesis and degradation of canine placental prostaglandins: prepartum changes in expression and function of prostaglandin F2\u03b1-synthase (PGFS, AKR1C3) and 15-hydroxyprostaglandin dehydrogenase (HPGD)","volume":"89","author":"Gram","year":"2013","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jsbmb.2025.106874_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.anireprosci.2008.12.011","article-title":"Time related changes in luteal prostaglandin synthesis and steroidogenic capacity during pregnancy, normal and antiprogestin induced luteolysis in the bitch","volume":"116","author":"Kowalewski","year":"2009","journal-title":"Anim. Reprod. Sci."},{"key":"10.1016\/j.jsbmb.2025.106874_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00441-021-03427-6","article-title":"Do uterine PTGS2, PGFS, and PTGFR expression play a role in canine uterine inertia?","volume":"385","author":"Rempel","year":"2021","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jsbmb.2025.106874_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/REP-09-0140","article-title":"Canine placenta: a source of prepartal prostaglandins during normal and antiprogestin-induced parturition","volume":"139","author":"Kowalewski","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.jsbmb.2025.106874_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00441-018-2915-x","article-title":"Expression of PTGS2, PGFS and PTGFR during downregulation and restart of spermatogenesis following GnRH agonist treatment in the dog","volume":"375","author":"K\u00f6rber","year":"2019","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jsbmb.2025.106874_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jsbmb.2017.11.013","article-title":"Steroidogenic enzymes, their products and sex steroid receptors during testis development and spermatogenesis in the domestic cat (Felis catus)","volume":"178","author":"Braun","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","article-title":"Comparative oncology: overcoming human cancer through companion animal studies","volume":"55","author":"Oh","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jsbmb.2025.106874_bib16","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1021\/jm9001633","article-title":"Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1)","volume":"52","author":"El-Kabbani","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106874_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0090-9556(25)08800-2","article-title":"Metabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide","volume":"20","author":"Tajima","year":"1992","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2025.106874_bib18","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1021\/acs.jmedchem.0c00939","article-title":"Development of novel AKR1C3 inhibitors as new potential treatment for castration-resistant prostate cancer","volume":"63","author":"Endo","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106874_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cbi.2016.12.018","article-title":"Instability of C154Y variant of aldo-keto reductase 1C3","volume":"276","author":"Endo","year":"2017","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib21","series-title":"Enzymology and Molecular Biology of Carbonyl Metabolism 12","first-page":"341","article-title":"Comparison of stereoselective reduction of 3- and 20-oxosteroids among mouse and primate 20\u03b1-hydroxysteroid dehydrogenases","author":"Ishikura","year":"2005"},{"key":"10.1016\/j.jsbmb.2025.106874_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105586","article-title":"Human dehydrogenase\/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: substrate and reaction specificity in the reduction of 11-keto-C19-steroids","volume":"199","author":"Endo","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0076-6879(90)89319-D","article-title":"Isoenzymes of alcohol dehydrogenase in retinoid metabolism","volume":"189","author":"Par\u00e9s","year":"1990","journal-title":"Methods Enzym."},{"key":"10.1016\/j.jsbmb.2025.106874_bib24","series-title":"Enzyme kinetics","first-page":"100","author":"Segel","year":"1975"},{"key":"10.1016\/j.jsbmb.2025.106874_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106113","article-title":"Porcine aldo-keto reductase 1C subfamily members AKR1C1 and AKR1C4: substrate specificity, inhibitor sensitivity and activators","volume":"221","author":"Endo","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2005.10.024","article-title":"Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues","volume":"248","author":"Sharma","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106574","article-title":"Involvement of porcine and human carbonyl reductases in the metabolism of epiandrosterone, 11-oxygenated steroids, neurosteroids, and corticosteroids","volume":"243","author":"Endo","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib28","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1158\/2767-9764.CRC-23-0235","article-title":"AKR1C3 converts castrate and post-abiraterone DHEA-S into testosterone to stimulate growth of prostate cancer cells via 5-androstene-3\u03b2,17\u03b2-diol","volume":"3","author":"Detlefsen","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.jsbmb.2025.106874_bib29","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac068","article-title":"Conversion of classical and 11-oxygenated androgens by insulin-induced AKR1C3 in a model of human PCOS adipocytes","volume":"163","author":"Paulukinas","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106874_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0009-2797(02)00206-5","article-title":"Selective and potent inhibitors of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone","volume":"143\u2013144","author":"Higaki","year":"2003","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib31","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/jb\/mvj109","article-title":"Molecular cloning of a novel type of rat cytoplasmic 17\u03b2-hydroxysteroid dehydrogenase distinct from the type 5 isozyme","volume":"139","author":"Ishikura","year":"2006","journal-title":"J. Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0022-4731(78)90194-2","article-title":"Androgen metabolism in the dog","volume":"9","author":"Yamamoto","year":"1978","journal-title":"J. Steroid Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib33","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/endo-103-6-2112","article-title":"Adrenarche: a survey of rodents, domestic animals, and primates","volume":"103","author":"Cutler","year":"1978","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106874_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2007.03.014","article-title":"Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma","volume":"104","author":"S\u00e1nchez-Archidona","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2019.04.005","article-title":"Circulating 11-oxygenated androgens across species","volume":"190","author":"Rege","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.588835","article-title":"Do dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) play a role in the stress response in domestic animals?","volume":"7","author":"Gabai","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.jsbmb.2025.106874_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep32198","article-title":"Dihydrotestosterone synthesis pathways from inactive androgen 5\u03b1-androstane-3\u03b2,17\u03b2-diol in prostate cancer cells: inhibition of intratumoural 3\u03b2-hydroxysteroid dehydrogenase activities by abiraterone","volume":"6","author":"Ando","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2025.106874_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/bs.vh.2018.01.007","article-title":"Dehydroepiandrosterone (DHEA)-SO4 depot and castration-resistant prostate cancer","volume":"108","author":"Penning","year":"2018","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.jsbmb.2025.106874_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2006.06.029","article-title":"Characterization of the canine 3\u03b2-hydroxysteroid dehydrogenase and its expression in the corpus luteum during diestrus","volume":"101","author":"Kowalewski","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159867","article-title":"11-Ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer: potent androgens which can no longer be ignored","volume":"11","author":"Pretorius","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2025.106874_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111189","article-title":"Back where it belongs: 11\u03b2-hydroxyandrostenedione compels the re-assessment of C11-oxy androgens in steroidogenesis","volume":"525","author":"Barnard","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.steroids.2012.12.011","article-title":"What are the physiological estrogens?","volume":"78","author":"Baker","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106874_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/EBC20230096","article-title":"Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives","volume":"68","author":"Ri\u017ener","year":"2024","journal-title":"Essays Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109335","article-title":"Estrogen sulfotransferase and sulfatase in steroid homeostasis, metabolic disease, and cancer","volume":"201","author":"Wang","year":"2024","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106874_bib45","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1210\/en.2006-0113","article-title":"Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor \u03b1 and \u03b2 subtypes: insights into the structural determinants favoring a differential subtype binding","volume":"147","author":"Zhu","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106874_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jsbmb.2025.106874_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2826.2011.02256.x","article-title":"Dehydroepiandrosterone sulphate: action and mechanism in the brain","volume":"24","author":"Dong","year":"2012","journal-title":"Neuroendocrinol"},{"key":"10.1016\/j.jsbmb.2025.106874_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/endo-99-2-602","article-title":"The formation of 5\u03b1-androstane-3\u03b1,17\u03b2-diol by dog prostate","volume":"99","author":"Jacobi","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106874_bib49","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/dmd.115.064295","article-title":"Characterization of the canine anthracycline-metabolizing enzyme carbonyl reductase 1 (cbr1) and the functional isoform cbr1 V218","volume":"43","author":"Ferguson","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2025.106874_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cbi.2014.09.023","article-title":"protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells","volume":"234","author":"Endo","year":"2015","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib51","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1046\/j.0014-2956.2001.02510.x","article-title":"Characterization of a major form of human isatin reductase and the reduced metabolite","volume":"268","author":"Usami","year":"2001","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/biof.1408","article-title":"Isatin, an endogenous nonpeptide biofactor: a review of its molecular targets, mechanisms of actions, and their biomedical implications","volume":"44","author":"Medvedev","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.jsbmb.2025.106874_bib53","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/bi036046x","article-title":"Crystal structure of human prostaglandin f synthase (AKR1C3)","volume":"43","author":"Komoto","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2025.106874_bib54","series-title":"Enzymology and Molecular Biology of Carbonyl Metabolism 13","first-page":"273","article-title":"Conversion of AKR1C20 into an AKR1C6-type enzyme by site-directed mutagenesis","author":"Endo","year":"2007"},{"key":"10.1016\/j.jsbmb.2025.106874_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/364787","article-title":"Placental origin of prostaglandin F2\u03b1 in the domestic cat","volume":"2014","author":"Siemieniuch","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jsbmb.2025.106874_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/REP-16-0180","article-title":"Synthesis and reception of prostaglandins in corpora lutea of domestic cat and lynx","volume":"152","author":"Zschockelt","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.jsbmb.2025.106874_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/vms3.642","article-title":"Comparative pathology of dog and human prostate cancer","volume":"8","author":"Ryman-Tubb","year":"2022","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.jsbmb.2025.106874_bib58","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/ani11030608","article-title":"Hormonal carcinogenesis in canine mammary cancer: molecular mechanisms of estradiol involved in malignant progression","volume":"11","author":"Torres","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.jsbmb.2025.106874_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1292\/jvms.56.581","article-title":"20\u03b1-hydroxysteroid dehydrogenase activity in canine spontaneous neoplasms","volume":"56","author":"Tanaka","year":"1994","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jsbmb.2025.106874_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cbi.2008.10.015","article-title":"AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids","volume":"178","author":"Skarydov\u00e1","year":"2009","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(00)00422-6","article-title":"Phytoestrogens inhibit human 17\u03b2-hydroxysteroid dehydrogenase type 5","volume":"171","author":"Krazeisen","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2008.10.024","article-title":"Type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin f synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs","volume":"178","author":"Byrns","year":"2009","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106874_bib63","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1016\/j.bmcl.2005.08.063","article-title":"Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents","volume":"15","author":"Gobec","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2025.106874_bib64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jb\/mvx041","article-title":"Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily","volume":"162","author":"Hara","year":"2017","journal-title":"J. Biochem"},{"key":"10.1016\/j.jsbmb.2025.106874_bib65","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00204-020-02818-y","article-title":"Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens ?","volume":"94","author":"Novotn\u00e1","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10637-014-0130-5","article-title":"In vitro and in vivo characterization of ASP9521: a novel, selective, orally bioavailable inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 5 (17\u03b2HSD5; AKR1C3)","volume":"32","author":"Kikuchi","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.jsbmb.2025.106874_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/mol.104.006569","article-title":"Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes","volume":"67","author":"Bauman","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jsbmb.2025.106874_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2008.09.029","article-title":"Structural basis for the selective inhibition of human 3\u03b2-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells","volume":"301","author":"Thomas","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib69","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1158\/1078-0432.CCR-12-0908","article-title":"Abiraterone inhibits 3\u03b2-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer","volume":"18","author":"Li","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2025.106874_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0960-0760(94)90270-4","article-title":"Novel aromatase and 5\u03b1-reductase inhibitors","volume":"49","author":"Di Salle","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106874_bib71","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FPC.0000000000000226","article-title":"Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases","volume":"26","author":"Platt","year":"2016","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.jsbmb.2025.106874_bib72","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/ani15030415","article-title":"Trilostane: beyond Cushing\u2019s syndrome","volume":"15","author":"Olaimat","year":"2025","journal-title":"Animals"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007602500202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:13:56Z","timestamp":1770804836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007602500202X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":72,"alternative-id":["S096007602500202X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106874","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canine aldo-keto reductase 1C3 (AKR1C3\/PGFS) exhibits 17\u03b2\/20\u03b1-hydroxysteroid dehydrogenase activity and is inhibited by trilostane","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106874"}}